Symbols / COEP Stock $16.21 +7.35% Coeptis Therapeutics Holdings, Inc.

Healthcare • Biotechnology • United States • NCM
COEP (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. The company's product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze cancer patients if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a chimeric antigen receptor (CAR) therapy for treatment for cancer. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

Stock Fundamentals
Scroll to Statements
Market Cap 100.88M Enterprise Value 95.30M Income -11.92M Sales 1.36M Book/sh 2.36 Cash/sh 1.02
Dividend Yield — Payout 0.00% Employees 4 IPO — P/E — Forward P/E -95.35
PEG — P/S 74.01 P/B 6.87 P/C — EV/EBITDA -8.03 EV/Sales 69.92
Quick Ratio 3.60 Current Ratio 4.16 Debt/Eq 1.91 LT Debt/Eq — EPS (ttm) -2.81 EPS next Y -0.17
EPS Growth — Revenue Growth — Earnings 2024-11-13 ROA -65.05% ROE -136.91% ROIC —
Gross Margin 86.75% Oper. Margin -230.65% Profit Margin 0.00% Shs Outstand 6.22M Shs Float 5.25M Short Float 7.00%
Short Ratio 7.94 Short Interest — 52W High 21.41 52W Low 6.26 Beta -0.43 Avg Volume 52.16K
Volume 90.90K Target Price — Recom None Prev Close $15.10 Price $16.21 Change 7.35%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$16.21
Latest analyst target
3. DCF / Fair value
$-8.77
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$16.21
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-09-22 init Ladenburg Thalmann — → Buy $3
2023-05-18 reit EF Hutton Buy → Buy $6
2023-05-10 reit EF Hutton — → Buy $6
2023-04-19 init JonesTrading — → Buy $4
2023-04-05 reit EF Hutton — → Buy $6
2023-03-29 reit EF Hutton — → Buy $6
2022-12-13 init EF Hutton — → Buy $6
2022-12-12 init EF Hutton — → Buy $6
News
RSS: Latest COEP news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-11 SALKIND GENE Director — 3,250 $0.00 $0
2026-02-11 SALKIND GENE Director — 5,700 $10.56 $60,192
2026-02-11 DESCHAMPS PHILIPPE Director — 3,250 $0.00 $0
2026-02-11 DESCHAMPS PHILIPPE Director — 5,700 $10.56 $60,192
2026-02-11 CALISE CHRIS Director — 3,250 $0.00 $0
2026-02-11 CALISE CHRIS Director — 5,700 $10.56 $60,192
2026-02-11 SHEEHY CHRISTINE ELISE Officer — 12,500 $0.00 $0
2026-02-11 SHEEHY CHRISTINE ELISE Officer — 1,000 $10.56 $10,560
2026-02-11 YERACE DANIEL ALEXANDER Officer and Director — 20,000 $0.00 $0
2026-02-11 YERACE DANIEL ALEXANDER Officer and Director — 10,000 $10.41 $104,100
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1.36
0.00
0.00
0.00
Operating Revenue
1.36
0.00
0.00
0.00
Cost Of Revenue
0.18
0.00
0.00
0.00
Reconciled Cost Of Revenue
0.18
0.00
0.00
0.00
Gross Profit
1.18
0.00
0.00
0.00
Operating Expense
14.23
+41.49%
10.05
-53.22%
21.49
-37.15%
34.20
Research And Development
1.28
-45.22%
2.33
-65.04%
6.67
+31825.33%
0.02
Selling General And Administration
11.95
+77.73%
6.72
-51.36%
13.82
-59.55%
34.18
Selling And Marketing Expense
0.10
0.00
-100.00%
0.01
+52.56%
0.01
General And Administrative Expense
11.84
+76.17%
6.72
-51.36%
13.82
-59.54%
34.17
Salaries And Wages
2.90
+2.71%
2.83
+46.34%
1.93
—
Other Gand A
8.94
+129.47%
3.90
-67.24%
11.89
-65.20%
34.17
Total Expenses
14.41
+43.28%
10.05
-53.22%
21.49
-37.15%
34.20
Operating Income
-13.04
-29.73%
-10.05
+53.22%
-21.49
+37.15%
-34.20
Total Operating Income As Reported
-13.04
-29.73%
-10.05
+53.22%
-21.49
+37.15%
-34.20
EBITDA
-10.41
-11.05%
-9.38
+53.40%
-20.12
+44.65%
-36.35
Normalized EBITDA
-11.58
-31.65%
-8.80
+57.48%
-20.69
+37.23%
-32.96
Reconciled Depreciation
1.22
+17.71%
1.04
+0.27%
1.04
+3.44%
1.00
EBIT
-11.63
-11.71%
-10.42
+50.78%
-21.16
+43.36%
-37.36
Total Unusual Items
1.17
+302.13%
-0.58
-201.97%
0.57
+116.73%
-3.39
Total Unusual Items Excluding Goodwill
1.17
+302.13%
-0.58
-201.97%
0.57
+116.73%
-3.39
Special Income Charges
0.16
+167.03%
-0.24
0.00
+100.00%
-3.39
Other Special Charges
-0.16
-179.52%
0.20
—
3.39
Write Off
0.00
-100.00%
0.04
0.00
0.00
Net Income
-11.92
-11.58%
-10.68
+49.78%
-21.27
+43.40%
-37.57
Pretax Income
-12.28
-12.87%
-10.88
+48.85%
-21.27
+43.40%
-37.57
Net Non Operating Interest Income Expense
-0.53
-131.09%
-0.23
-111.32%
-0.11
+50.70%
-0.22
Interest Expense Non Operating
0.64
+38.95%
0.46
+329.31%
0.11
-50.70%
0.22
Net Interest Income
-0.53
-131.09%
-0.23
-111.32%
-0.11
+50.70%
-0.22
Interest Expense
0.64
+38.95%
0.46
+329.31%
0.11
-50.70%
0.22
Interest Income Non Operating
0.12
-50.37%
0.23
—
—
Interest Income
0.12
-50.37%
0.23
—
—
Other Income Expense
1.29
+317.04%
-0.60
-279.18%
0.33
+110.52%
-3.16
Other Non Operating Income Expenses
0.12
+841.94%
-0.02
+93.02%
-0.24
-200.76%
0.23
Gain On Sale Of Security
1.01
+395.95%
-0.34
-160.18%
0.57
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-12.28
-12.87%
-10.88
+48.85%
-21.27
+43.40%
-37.57
Net Income From Continuing Operation Net Minority Interest
-11.92
-11.58%
-10.68
+49.78%
-21.27
+43.40%
-37.57
Net Income From Continuing And Discontinued Operation
-11.92
-11.58%
-10.68
+49.78%
-21.27
+43.40%
-37.57
Net Income Continuous Operations
-12.28
-12.87%
-10.88
+48.85%
-21.27
+43.40%
-37.57
Minority Interests
0.36
+82.87%
0.20
0.00
—
Normalized Income
-13.09
-29.56%
-10.10
+53.74%
-21.83
+36.12%
-34.18
Net Income Common Stockholders
-11.92
-11.58%
-10.68
+49.78%
-21.27
+43.40%
-37.57
Diluted EPS
—
-5.56
+66.43%
-16.56
+68.52%
-52.60
Basic EPS
—
-5.56
+66.43%
-16.56
+68.52%
-52.60
Basic Average Shares
—
1.92
+49.84%
1.28
+79.70%
0.71
Diluted Average Shares
—
1.92
+49.84%
1.28
+79.70%
0.71
Diluted NI Availto Com Stockholders
-11.92
-11.58%
-10.68
+49.78%
-21.27
+43.40%
-37.57
Amortization
1.00
+0.00%
1.00
+0.00%
1.00
—
Amortization Of Intangibles Income Statement
1.00
+0.00%
1.00
+0.00%
1.00
—
Depreciation Amortization Depletion Income Statement
1.00
+0.00%
1.00
+0.00%
1.00
—
Depreciation And Amortization In Income Statement
1.00
+0.00%
1.00
+0.00%
1.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
16.15
+81.33%
8.91
+94.89%
4.57
-42.25%
7.92
Current Assets
7.35
+599.15%
1.05
-39.92%
1.75
-55.61%
3.94
Cash Cash Equivalents And Short Term Investments
6.35
+1091.80%
0.53
-63.73%
1.47
-61.25%
3.79
Cash And Cash Equivalents
5.67
+964.83%
0.53
-63.73%
1.47
-61.25%
3.79
Cash Financial
5.67
+964.83%
0.53
-63.73%
1.47
-61.25%
3.79
Other Short Term Investments
0.68
0.00
—
—
Receivables
0.01
0.00
-100.00%
0.04
+382.70%
0.01
Accounts Receivable
—
—
0.00
-100.00%
0.01
Accrued Interest Receivable
0.01
0.00
-100.00%
0.04
0.00
Inventory
—
—
—
—
Prepaid Assets
0.99
+91.34%
0.52
+114.57%
0.24
+69.72%
0.14
Total Non Current Assets
8.80
+12.04%
7.86
+178.49%
2.82
-29.00%
3.97
Net PPE
0.03
-59.75%
0.07
-35.48%
0.11
+52.37%
0.07
Gross PPE
0.25
-0.23%
0.25
+106.84%
0.12
+45.94%
0.08
Accumulated Depreciation
-0.23
-22.52%
-0.18
-1219.12%
-0.01
-9.74%
-0.01
Properties
0.00
0.00
—
—
Buildings And Improvements
0.24
+0.00%
0.24
—
—
Machinery Furniture Equipment
0.01
-5.61%
0.01
-58.55%
0.03
+0.00%
0.03
Other Properties
—
0.06
-38.73%
0.10
+65.62%
0.06
Goodwill And Other Intangible Assets
0.92
+68.94%
0.54
0.00
—
Other Intangible Assets
0.92
+68.94%
0.54
—
—
Investments And Advances
7.86
+38.11%
5.69
0.00
—
Non Current Prepaid Assets
—
0.00
-100.00%
0.16
-54.55%
0.35
Other Non Current Assets
—
1.55
-39.15%
2.55
-28.14%
3.55
Total Liabilities Net Minority Interest
2.09
-58.63%
5.04
+34.18%
3.76
+8.51%
3.46
Current Liabilities
1.77
-60.82%
4.51
+51.01%
2.99
+37.56%
2.17
Payables And Accrued Expenses
0.93
-53.66%
2.01
+1.57%
1.98
+603.03%
0.28
Payables
0.89
-30.01%
1.27
-10.56%
1.42
+1333.74%
0.10
Accounts Payable
0.89
-30.01%
1.27
-10.56%
1.42
+1333.74%
0.10
Current Accrued Expenses
0.04
-94.43%
0.74
+32.55%
0.56
+205.47%
0.18
Current Debt And Capital Lease Obligation
0.12
-90.34%
1.23
+21.43%
1.01
-46.45%
1.89
Current Debt
0.10
-91.58%
1.19
+21.83%
0.97
-47.30%
1.85
Other Current Borrowings
0.10
-91.58%
1.19
+21.83%
0.97
-47.30%
1.85
Current Capital Lease Obligation
0.02
-55.38%
0.04
+11.19%
0.04
-8.58%
0.04
Current Deferred Liabilities
0.60
0.00
—
—
Current Deferred Revenue
0.60
0.00
—
—
Other Current Liabilities
0.12
-90.60%
1.28
—
—
Total Non Current Liabilities Net Minority Interest
0.32
-39.86%
0.53
-31.27%
0.77
-40.42%
1.29
Long Term Debt And Capital Lease Obligation
0.15
-11.18%
0.17
-20.03%
0.21
+28.20%
0.16
Long Term Debt
0.15
+0.00%
0.15
+0.00%
0.15
+0.00%
0.15
Long Term Capital Lease Obligation
0.00
-100.00%
0.02
-69.15%
0.06
+315.53%
0.01
Stockholders Equity
13.56
+300.99%
3.38
+315.51%
0.81
-81.72%
4.45
Common Stock Equity
13.56
+300.99%
3.38
+315.51%
0.81
-81.72%
4.45
Capital Stock
0.00
+168.69%
0.00
+19.55%
0.00
-90.85%
0.00
Common Stock
0.00
+171.23%
0.00
+18.44%
0.00
-90.85%
0.00
Preferred Stock
0.00
-100.00%
0.00
0.00
0.00
Share Issued
5.75
+171.57%
2.12
+19.79%
1.77
+80.57%
0.98
Ordinary Shares Number
5.75
+171.57%
2.12
+19.79%
1.77
+80.57%
0.98
Additional Paid In Capital
127.20
+23.52%
102.98
+12.33%
91.67
+29.95%
70.54
Retained Earnings
-109.95
-12.16%
-98.04
-12.23%
-87.36
-32.18%
-66.09
Treasury Stock
—
—
0.00
0.00
Minority Interest
0.51
+4.34%
0.49
0.00
—
Total Equity Gross Minority Interest
14.07
+263.78%
3.87
+375.11%
0.81
-81.72%
4.45
Total Capitalization
13.71
+288.21%
3.53
+266.42%
0.96
-79.06%
4.60
Working Capital
5.58
+261.24%
-3.46
-179.42%
-1.24
-170.03%
1.77
Invested Capital
13.81
+192.63%
4.72
+143.43%
1.94
-69.95%
6.45
Total Debt
0.27
-80.78%
1.40
+14.28%
1.22
-40.47%
2.06
Net Debt
—
0.80
—
—
Capital Lease Obligations
0.02
-69.15%
0.06
-38.34%
0.10
+76.12%
0.06
Net Tangible Assets
12.65
+345.26%
2.84
+248.94%
0.81
-81.72%
4.45
Tangible Book Value
12.65
+345.26%
2.84
+248.94%
0.81
-81.72%
4.45
Current Notes Payable
—
1.09
+24.33%
0.88
—
Derivative Product Liabilities
0.17
-53.34%
0.36
-35.53%
0.56
-50.47%
1.12
Notes Receivable
—
—
3.50
0.00
Other Equity Interest
-3.69
-136.60%
-1.56
+55.48%
-3.50
—
Preferred Stock Equity
—
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.60
-29.38%
-6.65
+8.15%
-7.24
-86.79%
-3.88
Cash Flow From Continuing Operating Activities
-8.60
-29.38%
-6.65
+8.15%
-7.24
-86.79%
-3.88
Net Income From Continuing Operations
-12.28
-12.87%
-10.88
+48.85%
-21.27
+43.40%
-37.57
Depreciation Amortization Depletion
1.22
+17.71%
1.04
+0.27%
1.04
+3.44%
1.00
Depreciation
1.22
+17.71%
1.04
+0.27%
1.04
—
Depreciation And Amortization
1.22
+17.71%
1.04
+0.27%
1.04
+3.44%
1.00
Other Non Cash Items
3.04
+83.24%
1.66
-81.01%
8.74
+75.40%
4.98
Stock Based Compensation
1.22
+10.02%
1.10
+131.41%
0.48
0.00
Asset Impairment Charge
—
—
—
—
Operating Gains Losses
-0.43
-178.72%
0.55
-73.12%
2.05
-92.76%
28.26
Gain Loss On Investment Securities
-0.27
-178.26%
0.35
-82.90%
2.05
-92.76%
28.26
Unrealized Gain Loss On Investment Securities
0.09
0.00
—
—
Change In Working Capital
-1.46
-1065.60%
-0.13
-107.25%
1.73
+413.82%
-0.55
Change In Receivables
-0.01
+96.87%
-0.23
-659.61%
-0.03
-282.70%
-0.01
Changes In Account Receivables
—
0.00
-100.00%
0.01
+200.00%
-0.01
Change In Inventory
—
—
—
—
Change In Prepaid Assets
-0.47
-299.67%
-0.12
-230.54%
0.09
+118.50%
-0.49
Change In Payables And Accrued Expense
-0.82
-2751.38%
0.03
-98.17%
1.70
+3352.08%
-0.05
Change In Accrued Expense
-0.44
-343.67%
0.18
-51.99%
0.38
+2300.36%
-0.02
Change In Payable
-0.38
-154.12%
-0.15
-111.35%
1.32
+3865.72%
-0.04
Change In Account Payable
-0.38
-154.12%
-0.15
-111.35%
1.32
+3865.72%
-0.04
Change In Other Working Capital
—
—
0.00
+573.25%
0.00
Change In Other Current Assets
—
—
—
0.00
Change In Other Current Liabilities
-0.16
-179.87%
0.20
+749.50%
-0.03
—
Investing Cash Flow
0.00
0.00
0.00
0.00
Cash Flow From Continuing Investing Activities
—
—
—
0.00
Net PPE Purchase And Sale
—
—
—
—
Purchase Of PPE
—
—
—
—
Capital Expenditure
—
—
—
—
Net Intangibles Purchase And Sale
—
—
—
0.00
Purchase Of Intangibles
—
—
—
0.00
Financing Cash Flow
13.74
+140.58%
5.71
+16.18%
4.92
-10.39%
5.49
Cash Flow From Continuing Financing Activities
13.74
+140.58%
5.71
+16.18%
4.92
-10.39%
5.49
Net Issuance Payments Of Debt
0.77
-35.68%
1.20
+308.53%
-0.57
+76.21%
-2.42
Issuance Of Debt
0.99
-46.49%
1.85
+184.62%
0.65
0.00
Repayment Of Debt
-0.22
+66.40%
-0.65
+46.86%
-1.23
+49.32%
-2.42
Long Term Debt Issuance
0.99
-46.49%
1.85
+184.62%
0.65
0.00
Long Term Debt Payments
-0.22
+66.40%
-0.65
+46.86%
-1.23
+49.32%
-2.42
Net Long Term Debt Issuance
0.77
-35.68%
1.20
+308.53%
-0.57
+76.21%
-2.42
Short Term Debt Issuance
—
—
—
—
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
7.52
+7417.30%
0.10
-98.11%
5.29
+61.77%
3.27
Common Stock Payments
—
—
—
0.00
Repurchase Of Capital Stock
—
—
—
0.00
Proceeds From Stock Option Exercised
0.00
-99.82%
0.50
+150.00%
0.20
-96.19%
5.25
Net Other Financing Charges
—
—
—
-0.61
Changes In Cash
5.14
+649.15%
-0.94
+59.68%
-2.32
-244.08%
1.61
Beginning Cash Position
0.53
-63.73%
1.47
-61.25%
3.79
+73.95%
2.18
End Cash Position
5.67
+964.83%
0.53
-63.73%
1.47
-61.25%
3.79
Free Cash Flow
-8.60
-29.38%
-6.65
+8.15%
-7.24
-86.79%
-3.88
Interest Paid Supplemental Data
0.01
+0.00%
0.01
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
7.52
+7417.30%
0.10
-98.11%
5.29
+61.77%
3.27
Issuance Of Capital Stock
12.97
+223.18%
4.01
-24.15%
5.29
+61.77%
3.27
Net Preferred Stock Issuance
5.46
+39.37%
3.91
0.00
—
Preferred Stock Issuance
5.46
+39.37%
3.91
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category